Stem Cell Leader Beike Biotech And China’s Tsinghua University Receive USD $4 Million For Stem Cell Reprogramming Laboratory

Beike Biotechnology, the leader in stem cell applications for medical treatment, has announced that it has formally established a world-class laboratory facility for the research of cell reprogramming and gene engineering, through a joint agreement with the Shenzhen Graduate School of China’s renowned Tsinghua University. [click link for full article]

More: continued here

Filed under: Stem Cell Research on November 12th, 2007